Cargando…

pS2 is an independent factor of good prognosis in primary breast cancer.

In breast cancer, oestrogen regulated genes, such as pS2, may be expressed in well differentiated tumours with a good prognosis. We have examined pS2 mRNA expression in 78 primary, untreated breast cancers and related pS2 expression to disease behaviour and known prognostic factors. pS2 mRNA express...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thompson, A. M., Hawkins, R. A., Elton, R. A., Steel, C. M., Chetty, U., Carter, D. C.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1993
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968288/ https://www.ncbi.nlm.nih.gov/pubmed/8318427

Ejemplares similares

PS2 mRNA expression adds prognostic information to node status for 6-year survival in breast cancer.
por: Thompson, A. M., et al.
Publicado: (1998)

Allelic imbalance at chromosome 17p13.3 (YNZ22) in breast cancer is independent of p53 mutation or p53 overexpression and is associated with poor prognosis at medium-term follow-up.
por: Thompson, A. M., et al.
Publicado: (1998)

p53 gene mRNA expression and chromosome 17p allele loss in breast cancer.
por: Thompson, A. M., et al.
Publicado: (1990)

Partial deletion of chromosome 11p in breast cancer correlates with size of primary tumour and oestrogen receptor level.
por: Mackay, J., et al.
Publicado: (1988)

Cyclic AMP binding proteins and prognosis in breast cancer.
por: Miller, W. R., et al.
Publicado: (1990)

Primary systemic therapy for operable breast cancer.
por: Anderson, E. D., et al.
Publicado: (1991)

Response to endocrine manipulation and oestrogen receptor concentration in large operable primary breast cancer.
por: Anderson, E. D., et al.
Publicado: (1989)

High tPA-expression in primary melanoma of the limb correlates with good prognosis
por: Ferrier, C M, et al.
Publicado: (2000)

Primary systemic therapy for operable breast cancer--10-year survival data after chemotherapy and hormone therapy.
por: Cameron, D. A., et al.
Publicado: (1997)

p53 mutation, deprivation and poor prognosis in primary breast cancer
por: Baker, L, et al.
Publicado: (2010)

PS on good form
Publicado: (1971)

Gene expression in oestrogen-dependent human breast cancer xenograft tumours.
por: Thompson, A. M., et al.
Publicado: (1990)

Constitutional p53 mutation in a non-Li-Fraumeni cancer family.
por: Prosser, J., et al.
Publicado: (1992)

Carbonic anhydrase XII is a marker of good prognosis in invasive breast carcinoma
por: Watson, P H, et al.
Publicado: (2003)

pS2 and response to adjuvant hormone therapy in primary breast cancer.
por: Spyratos, F., et al.
Publicado: (1994)

High-dose chemotherapy supported by peripheral blood progenitor cells in poor prognosis metastatic breast cancer--phase I/II study. Edinburgh Breast Group.
por: Cameron, D. A., et al.
Publicado: (1996)

FKBPL: a marker of good prognosis in breast cancer
por: Nelson, Laura, et al.
Publicado: (2015)

Epidermal growth factor receptors in intracranial and breast tumours: their clinical significance.
por: Hawkins, R. A., et al.
Publicado: (1991)

Critical determination of the frequency of c-erbB-2 amplification in breast cancer.
por: Hubbard, A. L., et al.
Publicado: (1994)

p53 mutant breast cancer patients expressing p53γ have as good a prognosis as wild-type p53 breast cancer patients
por: Bourdon, Jean-Christophe, et al.
Publicado: (2011)

Allele loss from 5q21 (APC/MCC) and 18q21 (DCC) and DCC mRNA expression in breast cancer.
por: Thompson, A. M., et al.
Publicado: (1993)

An immunohistochemically positive E-cadherin status is not always predictive for a good prognosis in human breast cancer
por: Querzoli, P, et al.
Publicado: (2010)

Does the oestrogen receptor concentration of a breast cancer change during systemic therapy?
por: Hawkins, R. A., et al.
Publicado: (1990)

Immunoradiometric detection of pS2 and total cathepsin D in primary breast cancer biopsies: their correlation with steroid receptors.
por: Marsigliante, S., et al.
Publicado: (1994)

Primary Leiomyosarcoma of Bone: Analysis of Prognosis
por: Brewer, P., et al.
Publicado: (2012)

Immunohistochemical localisation of pS2 protein in ductal carcinoma in situ and benign lesions of the breast.
por: Luqmani, Y. A., et al.
Publicado: (1993)

Overexpression of p53 protein in primary Ewing's sarcoma of bone: relationship to tumour stage, response and prognosis
por: Abudu, A, et al.
Publicado: (1999)

Notch inhibition allows oncogene independent generation of iPS cells
por: Ichida, Justin K., et al.
Publicado: (2014)

Good Science, Good Sense and Good Sensibilities: The Three Ss of Carol Newton
por: Smith, Adrian J., et al.
Publicado: (2016)

Rho-GTPase activating-protein 18: a biomarker associated with good prognosis in invasive breast cancer
por: Aleskandarany, Mohammed A, et al.
Publicado: (2017)

Prognosis based on primary breast carcinoma instead of pathological nodal status.
por: Ménard, S., et al.
Publicado: (1994)

The cytochemical detection of oestrogen receptors in fine needle aspirates of breast cancer; correlation with biochemical assay and prediction of response to endocrine therapy.
por: Hawkins, R. A., et al.
Publicado: (1988)

Doxorubicin and vinorelbine act independently via p53 expression and p38 activation respectively in breast cancer cell lines
por: Liem, A A, et al.
Publicado: (2003)

Pyrethroid and Neonicotinoid Poisoning: A Good Prognosis
por: Vikhe, Vikram B, et al.
Publicado: (2023)

Prospective evaluation of prognostic factors in operable breast cancer.
por: Hawkins, R. A., et al.
Publicado: (1996)

Oestrogen-regulated protein SLC39A6: a biomarker of good prognosis in luminal breast cancer
por: Althobiti, Maryam, et al.
Publicado: (2021)

MICA/B and ULBP1 NKG2D ligands are independent predictors of good prognosis in cervical cancer
por: Cho, Hanbyoul, et al.
Publicado: (2014)

Changing the role of pCR in breast cancer treatment - an unjustifiable interpretation of a good prognostic factor as a “factor for a good prognosis“
por: Ivanovic, Nebojsa, et al.
Publicado: (2023)

MIB-1 labelling index is an independent prognostic marker in primary breast cancer.
por: Jansen, R. L., et al.
Publicado: (1998)

Nuclear ING3 Expression Is Correlated With a Good Prognosis of Breast Cancer
por: Wu, Xiaoyan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vhon7om8gq4dmibpfj7s5ucbb7